SCHEMBL694664

SCHEMBL694664

CC(=O)Oc1cccc(CC(C)N)c1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.63
CYP3A4 P08684 1/20 0.53
LMNA P02545 1/20 0.53
ACHE P22303 4/20 0.49
PNMT P11086 1/20 0.49
HTR2A P28223 2/20 0.47
HTR2C P28335 2/20 0.47
HTR2B P41595 2/20 0.47
SLC6A2 P23975 2/20 0.47
MAOA P21397 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
CYP2A6 P11509 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
PARP1 P09874 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694663 1.00 TAAR1 (0.63) TAAR1CYP3A4LMNAACHEPNMT
SCHEMBL1787452 0.89 CYP3A4 (0.54) TAAR1CYP3A4LMNAACHEMAOA
SCHEMBL3156480 0.88 SLC7A5 (0.59) CYP3A4LMNAHTR2A
SCHEMBL27864671 0.84 TAAR1 (0.59) TAAR1ACHEPNMTHTR2AHTR2C
Bromide SCHEMBL11271654 0.83 HTR2A (0.55) TAAR1HTR2AHTR2CHTR2BSLC6A2
SCHEMBL19759404 0.83 TAAR1 (0.71) TAAR1PNMTHTR2AHTR2CHTR2B
SCHEMBL9638163 0.82 ACHE (0.50) CYP3A4LMNAACHEPARP1
SCHEMBL2913614 0.81 CYP3A4 (0.58) CYP3A4LMNAACHEPARP1
SCHEMBL28506588 0.81 SLC6A4 (0.59) TAAR1LMNASLC6A2SLC6A4SLC6A3
SCHEMBL14478245 0.81 SLC6A4 (0.59) TAAR1LMNASLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421849-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Theravance, Inc. (US) 2012-02-29 EP disclosed
WO-2010123766-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITY THERAVANCE, INC. (US) 2010-10-28 WO disclosed